​

BMSystems in the world. A strong International Scientific exposure. Participations to International Scientific conferences as speaker

​

• 2023: ANNOUNCEMENT: Paris, Decembre 12-13,, 2023: GEMMA: BMSYSTEMS is invited to  Biofit 2023 (December 12-13, 2023) conferences to present its novel Autism (ASD) therapy (CADI-T2011) for the alleviation of ASD core symptoms ready for validation and to announce the world's first guide to help clinicians and parents to better care for ASD patients

• 2023: ANNOUNCEMENT: Paris November 22-23, 2023: GEMMA: BMSYSTEMS is invited to Polepharma Microbiomics (November 22-23, 2023)  conference to present its novel Autism (ASD) therapy (CADI-T2011) for the alleviation of ASD core symptoms ready for validation and to announce the world's first guide to help clinicians and parents to better care for ASD patients

• 2022 ANNOUNCEMENT: Rouen, December 14'-15, 2022: GEMMA: BMSystems is invited to the 3rd edition of the PolePhamra microbiota conference on December 14-15, 2022 to present its novel, ready for validation, CADI-T2011 microbiota treatment for alleviating gastrointestinal dysfunctions and attenuate the socio-cognitive consequences of ASD.

• 2022:ANNOUNCEMENT: Strasbourg November 29-30, 2022: GEMMA:Manuel Gea, CEO & VP R&D IT BMSystems is invited to the Biofit Event in Strasbourg to participate to the round table "How is the digital era shaping new forms of early-stage collaborations in biopharma".GEMMA Program used to illustrate the pitch 

• 2021: ANNOUNCEMENT: Paris December 14, 2021: BMSystems will be participating as speaker and panelist to Polepharma "Future of the Industry" conference (the N°1 pharmaceutical cluster in Europe) event to present its Artificial Intelligence  vision and expertise

• 2021: December 7-9,2021. France: Manuel Gea CEO & VP R&D IT BMSystems will be happy to meet potential partners during digital BioFit partnering event to present our latest innovations and diagnostic and therapeutic solutions.

• 2021: December 9-11, 2021. Belgium: Manuel Gea CEO & VP R&D IT BMSystems will be happy to meet potential partners during digital Biowinday partnering event to present our latest innovations and diagnostic and therapeutic solutions.

• 2020: INTERVIEW BFM Business TV : June 6, 2020 Regardez l'interview vidéo (10mn) du 6 juin de Manuel GEA - Bio-Modeling Systems Gea par Fabien Guez sur BFM Business TV qui décrypte le rôle méconnu du Taylorisme, son application irresponsable et ses conséquences dramatiques dans la crise actuelle et les futures.

• 2019: PRESS RELEASE: Paris November 6, 2019: Bio-Modeling Systems updates its pipeline of therapies, diagnostics, and bioprocesses and invites you to meet its team at BioFit and Polepharma Bio-Production conferences.

• 2019: ANNOUNCEMENT: Lyon October 17-18, 2019: Bio-Modeling Systems invited at the India-France Knowledge Summit 2 to contribute with its CADI Discovery Platform, the other AI, successfully applied to its Indo-French metabolic disorders therapeutic program: UMANG (now Arbuza Regenerate company) addressing  a public health issue concerning 50-100 millions children in India. 

• 2019: PRESS RELEASE: Paris October 1, 2019: Bio-Modeling Systems the Mechanisms-Based Cosmetics company, is invited to present its CADI™ Discovery platform and 7 outputs at the open Innovation sessions of Cosmetic-360

• 2019: ANNOUNCEMENT: Lille Juily 2-4, 2019: GEMMA: BMSystems invited as speaker at ANTIMIC 2019: Bacteriophages, Genius and success of precision medicine in infections (ATC HCl) and new tracks for microbiote “surgery” controt with GEMMA microbiota &Autism H2O2O program 

• 2019: ANNOUNCEMENT: Paris May 5, 2019: Bio-Modeling Systems is participating to Neurodegenerative Drug Development Europe Conference in Paris (May 22-23, 2019). Meet us to discover our Alzheimer's and Parkinson’s diseases solutions.

• 2019: ANNOUNCEMENT: GEMMA: Paris April 3, 2019: BMSystems will be participating to Polepharma microbiota conference (the N°1 pharmaceutical cluster in Europe) event to present its GEMMA microbiota &Autism H2O2O program.

• 2018: December 5, 2018. France: Manuel Gea CEO & VP R&D IT BMSystems will be happy to meet potential partners during BioFit partnering event to present our latest innovations and diagnostic and therapeutic solutions.

• 2018: December 4, 2018. Louvain Belgium: Manuel Gea CEO & VP R&D IT of BMSystems is invited, as Keynote speaker, to present CADI™ Discovery platform and operational successes at the "Artificial Intelligence for Health: between Dream and Reality" BioWin Day that gathers 600 participants organized by the BioWin life sciences and healthcare cluster in Wallonia. 4.

• 2018: November 6-7, 2018. Utrecht Netherland: Dr. François Iris, CSO of BMSystems is invited to present at the International OpenMultiMed COST TRAINING SCHOOL, (network of excellence funded by the E.C.) its "CFS-Low-grade inflammation" diagnostic and therapeutic CADI Discovery program.

• 2018: November 6, 2018. France: Manuel Gea CEO & VP R&D IT of BMSystems is invited to present at the French Government Defense procurement and technology agency its Gulf War Syndrome Low-grade inflammation diagnostic and therapeutic CADI Discovery program.

• 2018: ANNOUNCEMENT: Paris September 10, 2018: The key reasons why CADI Discovery was invented  in 2004 explained in  Current Opinion in Pharmacology:  How scientific literature analysis yields innovative therapeutic hypothesis through integrative iterations

• 2018: ANNOUNCEMENT: Paris May 28, 2018 Bio-Modeling Systems est heureuse de vous informer sur ses interventions lors des conférences suivantes

• 2018: ANNOUNCEMENT: Paris June 19-20, 2018: BMSystems invited to the Micorbiota conference organised by Adebiotech to present its microbiota vision and the corresponding CADI™ Discovery programs 

• 2018: ANNOUNCEMENT: Paris June 14, 2018: BMSystems & its partner Bolero invited to the Connected Health Conference organised by  ANRT at Sanofi France to present their Real life data strategy and implementations

• 2018: ANNOUNCEMENT: Paris March 13-14, 2018: BMSystems invited to the Epigentic conference organised by Adebiotech to present its CADI Discovery program EPIGEN-DIAB with the Centrer of excelllence in Eipgenetic in India 

• 2017: PRESS-RELEASE: Paris-November 16, 2017:BMSystems is selected to pitch at the “Translational Neurosciences Conference” organized by “NeurATRIS” and supported by “eartis” the European Infrastructure For Translational Medicine, comprising more than 80 leading European Institutes. 

• 2017: PRESS-RELEASE: Paris-New-York October 4, 2017: BMSystems, with its 14 independently validated successes to date, is selected by the Galien Foundation for the MedStartUp Award 2017program first step during the US Galien Prize Forum in New-York.

• 2017: ANNOUNCEMENT:  Latest news:  Press-release from Hospices Civils de Lyon about phage therapy success with Pherecydes Pharma bacteriophages. Pherecydes-Pharma, is BMSystems’ first therapeutic spin-off.

• 2017: ANNOUNCEMENT: Paris September 7, 2017: The future of Medicine: Bio-Modeling Systems invited to present at the Summer Universities of Fédération Hospitalière de France

• 2017: ANNOUNCEMENT: Belgium August 26-27, 2017: BMSystems selected to meet Wallonia life Sciences Companies and is invited to the Spa-Francorchamps Formula 1 Race. Great place for top meeting!

• 2017: ANNOUNCEMENT: Paris July 4, 2017. BMSystems was intited to present at the Conference INSEAD Alumni at BCG Paris Office: Everything you always wanted to know about Digital Health revolution “big promises” but were afraid to ask!

• 2017: ANNOUNCEMENT: Paris April 24, 2017: BMSytems was invited at the The Licensing Executives Society International (LESI) Annual Event Re-Inventing Healthcare: Digital Health and IP to present its Computer Augmented Deductive Intelligence platform and its operational successes

• 2017: ANNOUNCEMENT: Paris January 17, 2017: BMSytems was invited at the France-India healthcare Summit to present its Computer Augmented Deductive Intelligence platform and its operational successes

• 2016: ANNOUNCEMENT: May 9, 2016: CMC-Strategy Forum Europe. Manuel GEA Chairman Adebiotech and CEO BMSystems invited to present French biotech / Bioproduction Competitiveness and BMSystems' best practices. 

• 2016: ANNOUNCEMENT: April 7, 2016: Genople center: BMSystems invited to preent: A smart data approach to change the discovery paradigm. Presentation of CADI™-discovery programs and technology. 

• 2016: ANNOUNCEMENT: March 16, 2016; BMSystems invited to the Adebiotech conference to present its CADI Discovery paradigm to fight againt multiresistance infections  

• 2016: ANNOUNCEMENT: Februray 12, 2016 Berlin: BMSystems invited to the Conference "IP in Life Sciences Digital Health" to present CADI Discovery answers to big data issues and biases in scientific publications

• 2016: ANNOUNCEMENT: Februray 3, 2016 Paris: BMSystems invited  to the conference "Big Data a chance for healthcare?" to present CADI Discovery answers to big data issues and biases in scientific publications 

• 2015: ANNOUNCEMENT: December 7, 2015: BMSystems invited to present its CADI Discovery program in allergy: A systems approach to identify weak allergens/sensitizers capable of synergistic effects

• 2015: ANNOUNCEMENT : November 27, 2015: BMSystems invited to present its industrial biotech / synthetic biology strategy and achievements at the Synthetic Biology Conference organized by AllEnvi  that represent the leading research institutions in France dedicated to the environment issues

• March 31,2015. Vienna 23 rd European Psychiatry Association Congress.  Dr. François Iris invited to present our latest discoveries of our European's DECIUS program with the Max Planck Institute for Psychiatry in Munich: Presentation title: Differential proteomics data integration reveals anxiety-associated molecular and cellular mechanisms in cingulate cortex synapses..

• March 9, 2015 Paris, 09:00–10:30, Bio-Europe Spring: BMSystems invited as panelist with Sanofi, Johnsons & Johnson Innovation and the Institute of Cardiometabolism and Nutrition (ICAN) to share the achievements of Mechanisms-Based Medicine during the session: Translational medicine: From discovery to early stage drug development.

• 2014: November 5, 2014 Paris: BMSystems invited to present at the 2nd "Innovative Therapeutic Conference" its dual digital/biology "Mechanisms-Based Medicine" CADI Discovery Platform to address the major Therapeutic Innovation issues 

• 2014: October 9, 2014 Brussels: BMSystems invited to contribute as innovative SME model, at a policy roundtable at the European Parliament about: Lost in translation? How to get healthcare biotech from lab to clinic, for a healthier, wealthier Europe 

• 2014: September 30, 2014: BMSystems invited to contribute to the "Université d'été of AFSSI session on innovation  strategies and funding

• 2014: March 6, 2014: BMSystems and Persistent Systems invited to present their collaborative strategy and business solutions at the Cloud Computing and BigData emerging programs workshop organized by "Medicen, Systematic, Capdigital" clusters

• 2014: European Commission: consortium CASyM:  BMSystems selected in the Europe-wide inventory of industry involve in Systems Medicine of The Coordinating Action Systems Medicine (CASyM)

• 2014: Feb. 19-20, 2014: BMSystems invited to explain its R&D strategy and its collaborative strategy with Aepodia its R&D Belgium partner in Fibromyalgia and facial pain.

• 2014: Feb. 11, 2014 Lyon: BMSystems and Persistent Systems invited to present their collaborative strategy and business solutions at the Inria-Industry confernece on Bio-Informatics and tools for the Healthcare sector.

• 2014: Jan.. 28, 2014 Paris France: BMSystems invited to present its e Health  strategy at the "Medicen-Systematic, Capdigital" world clusters workshop

• 2013: Nov. 27, 2013 Paris: BMSystems was invited to present its Indian IT strategy at CEFIPRA conference

• 2013: October 20-23, 2013 Logonna-Daoulas Brittany France: BMSystems invited  to present : Calcium signaling alterations in neuropsychiatry: “Biomarker” becomes a functionally very indirect and context dependent concept" at he "Calcium signaling as a hub for translational medicine and starting point to model life" workshop co-organized by Inserm, CNRS and the European Calcium Society

• 2013: October 17-18, 2013 Paris France: BMSystems invited to present its innovative "global systems heurisitc modeling apporach" at the Workshop Neurosciences Medicen-BioMaryland

• 2013: October 8, 2013 Paris France: BMSystems is on the three SME invited to present its e Health strategy & program in psychiaty at the "Grand Paris e-Health cluster" workshop

• 2013: September 6, 2013 Paris France: BMSystems invited to present its e Health  strategy at the "Medicen-Systematic, Capdigital" clusters workshop

• 2013: July 8, 2013 Paris France: BMSystem invited to present its Global R&D strategty and its R&D collaboration with Persitent Systems at the 6th Meeting of the Indo-French CEOs Forum 8-9 July 2013

• 2013: June 26, 2013 Paris France: BM-Systems’ CSO (Dr. François Iris) is invited at the Teratec international forum (High performance Computing) to present our approaches to effective “Systems Medicine”.

• 2013: May 3-4 Munich Germany: BMSystems invited at the 9th International Workshop on Computational Neuropsychiatry on Systems Psychiatry of Stress, anxiety and Addiction to present the first scientific results of its CADI DECIUS research program on molecular pathways of chronic anxiety. 

• 2013: March 24-26 Lyon France: BMSystems invited to contribute to the experts discussions at the 1st  "Coordinating Actions Systems-Medicine" stakeholders conference supported by the European Commission during BioVision the world  life sciences forum.

• 2012: Dec. 7, Pune India: BMSystems invited at 7th Biocrats conference to present its new CADI approach and its latest achievements in a major life sciences country 

• 2012: Nov. 11, Hamburg Germany: BMSystems invited to present its cancer research and reveal its disruptive therapeutic concept at European Cancer Cluster Conference.

• 2012: Nov. 8-10, Nanjing China: BMSystems invited to present at the 10th International Drug Discovery Science & Technology : Title of the presentation: The discovery of Innovative Therapeutic Approaches: Under the Street Light is not Necessarily the Right Place to Search!

• 2012: Brussels, May 30, 2012: BMSystems invited to present its innovative business model and latest achievements in CNS at the European Commission Fit for health conference

• 2012: Munich, May 11-12, 2012: BMSystems' CSO François Iris, is invited as session chairman to the 8th International Workshop on Computational Neuropsychiatry: Sleep, Affective disorders and Schizophrenia - An integrated view.

• 2012: Paris, March 30, 2012: BMSystems was invited as innovative SME to present during the Horizon 2020, European Commission program conference.

• 2011: La Rochelle France, November, 14-16 2011: New Frontiers in biotechnologies organized by INRA and CNRS. Bio-Modeling Systems invited to present its diruptive innovation successfully applied in the field of industrial biotech.

• 2011: Berlin Germany, October 11-13,  2011: 4th Franco-German Research Forum, Industrial biotech Workshop: Bio-Modeling Systems invited to participate as Synthons program member to contribute to the future programs with the German delegation.

• 2011: Paris France, September 26-28  2011 : 2nd Innovation Days: Looking Ahead: Personalized Medicine: "From statistical biomarkers to pertinent biomarkers related to mechanisms".

• 2011: Vienna Austria, March 12-15  2011 : 19th European Congress of Psychiatry: organized by the European Psychiatric Association (EPA),the largest international association of psychiatrists in Europe. Dr. François IRIS is invited to present:Methodology of Mapping in Integrative Molecular Biology associated to psychiatric and cognitive disorders. (Session location: Molecular Systems Biology in Psychiatric Disorders :15.03.2011 - 16:15-17:45 Hall O).

• 2010: Amiens France november 4-5, 2010: 3rd British-French Workshop Green Chemistry conference: BMSystems is invited to present the collaborative Synhons platform (ARD, IBT, CVG, BMSystems, L'Oréal, Arkema, Rhodia) and its latest achievements.

• 2010: Presqu'ile de Giens France: October 11-15, 2010: Molecular microbiology conference organized by the CNRS with the support or INSERM, Institute Pasteur, and INRA. Dr. Francois Iris is invited to present BMSystems' expertise and achievements in the field of bacteria/phages research .

• 2010: Philadelphia USA September 14, 2010: French Biotech Tour. Bio-Modeling Systems was invited to present to a panel of US Pharma companies.

• 2010: Brussels June 14-15, 2010: The DG Research invited BMSystems to contribute his expertise to the scientific meeting "From Systems Biology to Systems Medicine".

• 2010 : BiO Chicago USA May 3-6, 2010 : BMSystems was selected by French life science clusters to present its disruptive science & business model during BiO in Chicago.

• 2010: Brussels may 20-21, 2010.BMSystems is invited by the European Commission to present its disruptive R&D and business model innovation during the international conference:Innovation in Healthcare. From Research to Market. SMEs in focus.

• 2010: Croatia May 9-13 2010 .COST (European Cooperation in Science and Technology) program.BMSystems is invited to give three lectures and to participate to  students' projects evaluation at the Research Training School on Systems Biology.

• 2010:  Munich May 7-8, 2010 . 6th International Workshop on Computational Neuropsychiatry. BMSystems is invited to co-present  with Dr. Christopher TURCK (Max Planck Instute. for Psychiatry, Munich) Pathways of Proteomics in depression - data and modeling.

• 2009: Brussels Belgium: October 20-21, 2009: BE Live IT 2009 CEA Life Sciences-SEPIA researcher and Bio-Modeling Systems CSO will present their original and productive work in the field of neurodegenerative diseases  (Creutzfeldt-Jakob disease understanding ).

• 2009: Atlanta USA May 18-21, 2009: BMSystems was selected to present BioXplain at BiO.

• 2009 Houston USA.May 3-7, 2009:.12th annual NSTI Nanotech NSTI Nanotech: Phage Nanobiotechnology symposium

• 2009: 4th Annual Biomarkers Congress. Manchester UK February 26-27, 2009: Dr. Francois Iris, founder & CSO of BMSystems, invited as keynote speaker

• 2008: London UK. December 15-16, 2008: 1st Annual CNS Drug Development Conference. Biomarkers in CNS diseases: can serendipity lead to relevance?

• 2008: Brussels Belgium, 30-31 October: 2008  BE Live IT:  Biomarkers in medical biotech discovery

• 2008: Brussels Belgium, 30-31, October 2008: BE Live IT: Industrial biotech session with our Synthons platform partner A.R.D.

• 2008: Brussels Belgium, 16-17, September 2008: European Forum for industrial Biotech organized by Europabio: Synthons platform presentation with our partner A.R.D

• 2008: Edinburgh Scotland U.K. July 26-29, 2008: International Phage Conference

• 2008: Atlanta Georgia USA, June 23-25, 2008: 12th Biodetection Technologies conference

• 2008: Manchester U.K. May 14-15, 2008: 3rd Annual Biomarkers Congress;

• 2007: London U.K. March 12-15,  2007: Drug Discovery Technologies

• 2007: Munich Germany January 23, 2007: Integrative Biology conference Max Planck Institute

• 2006: San Francisco California USA, June 19-21, 2006: Beyond Genome

• 2005: Dusseldorf Germany. October 19-21, 2005: Prion European conference, Presentation   CADI model by CEA Prion tea

• 2006: London U.K. March 13-16 , 2006: Drug Discovery Technologies.

• 2005: Orlando Florida USA, December 9, 2005:Metabolic profiling conference.

• 2005: London UK, March 15-16, 2005: Pharma Solutions Conference.

• 2004: Lyon France, November 25, 2004: Systems Biology conference at the Sun Microsystems conference center.

• 2004: Paris, France June 24, 2004: Systems Biology conference at the Sun Microsystems conference center.

• 2003: Ottawa Canada, November 17, 2003:BioNorth conference.

• ​

BMSystems Bio-business conferences participations (international events only)

​

• 2015: Confernce Cosmetic Valley: Paris October 16, 2015

• 2015: Afssi conference Dijon July 06-07, 2015

• 2015: Bio-Europe Spring Paris March 9, 2015

• 2014: IMI STAKEHOLDER FORUM 2014 - Stakeholder Forum 2014 in Brussels May 21, 2014.

• 2014: IMI - JDRF Diabetes Patient Focus meeting in Brussels May 20, 2014

• 2012: Bio-Europe, Hamburg November, 12-14, 2012

• 2012: Bio US Boston, June 18-21, 2012

• 2012: European commission Conference: Innovation in Healthcare without borders, Brussels, Belgium 16-17 April 2012 

• 2011: Bio-Europe, Dusseldorf, Germany: October 31-November 2, 2011

• 2011: BiO, Washington, USA : June 27-30, 2011

• 2010: Bio Europe, Munich, Germany, November 15-17, 2010

• 2010: BiO Chicago, USA,:May 3-6, 2010 

• 2009: Bio-Europe, Wienna  Austria ::November 2-4, 2009

• 2009: BiO ,Atlanta USA: May 18-21, 2009

• 2008: Bio-Europe, Mannheim, Germany:  November 17-19, 2008

• 2008: EuroBiO, Paris, France: October  6-8, 2008 

• 2007: EuroBiO, Lille, France September 25-26, 2007 

• 2007: BiO Boston USA May 6-9, 2007 

• 2005: BioSquare Lyon, France , April 13-15 2005

• 2004: Bio-Europe Germany November 8-10 2004

• 2004: BioSquare Switzerland March 10-12, 2004

• 2003: Profession: Bio-Entrepreneur Paris, France: March 12-13, 2003